InvestorsHub Logo
Followers 4
Posts 1270
Boards Moderated 0
Alias Born 05/17/2012

Re: jeffqdhsr post# 7475

Sunday, 01/07/2018 8:34:21 PM

Sunday, January 07, 2018 8:34:21 PM

Post# of 14845
I thought we were looking at a buyout in the short term but Art Przybyl may have positioned the company for something else. Who knows. He is very good at finding revenue and it looks like this year will be really different because of tax changes and other coming legislation that is pro-business. We got that big Lithobid contract, I think we will get more.
The corti drug deal is so expensive and as I said it makes me uncomfortable because there are so many other areas where bioidentical/biosimilar drugs are the way to go. I am NOT a medical person. It is just a sense. Synthetic corticotropin is used successfully in other countries.Maybe there are indications for only porcine based acthar gel.
I really like the new FDA director. I think we will see Libigel approved finally. All this is jmo. I appreciate your input!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News